plavix

Pharmacogenomics This week on Health Connect South Radio we featured Bob Bean, CEO of Harmonyx, a technology company specializing in pharmacogenomics. Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop […] The post Pharmacogenomics appeared first on Business RadioX ®.

A conversation between Robert Goldberg, MD, and Yoash Enzer, MD. All patients on aspirin or warfarin were once advised to stop taking these anticoagulants two weeks before surgery. But new evidence shows that many patients suffer serious thrombotic events as a result, underscoring the need for a more measured approach. In today’s discussion, Dr. Yoash Enzer, clinical associate professor at Brown University, offers practical advice on how to balance the risk of bleeding with the risk of thromboembolism. (November 2010)